JP2009516726A5 - - Google Patents

Download PDF

Info

Publication number
JP2009516726A5
JP2009516726A5 JP2008541808A JP2008541808A JP2009516726A5 JP 2009516726 A5 JP2009516726 A5 JP 2009516726A5 JP 2008541808 A JP2008541808 A JP 2008541808A JP 2008541808 A JP2008541808 A JP 2008541808A JP 2009516726 A5 JP2009516726 A5 JP 2009516726A5
Authority
JP
Japan
Prior art keywords
filler
parts
pharmaceutical composition
azd2171
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008541808A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009516726A (ja
Filing date
Publication date
Priority claimed from GBGB0523810.0A external-priority patent/GB0523810D0/en
Application filed filed Critical
Publication of JP2009516726A publication Critical patent/JP2009516726A/ja
Publication of JP2009516726A5 publication Critical patent/JP2009516726A5/ja
Pending legal-status Critical Current

Links

JP2008541808A 2005-11-23 2006-11-21 医薬組成物 Pending JP2009516726A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0523810.0A GB0523810D0 (en) 2005-11-23 2005-11-23 Pharmaceutical compositions
PCT/GB2006/004320 WO2007060402A1 (en) 2005-11-23 2006-11-21 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
JP2009516726A JP2009516726A (ja) 2009-04-23
JP2009516726A5 true JP2009516726A5 (cg-RX-API-DMAC7.html) 2010-01-21

Family

ID=35601030

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008541808A Pending JP2009516726A (ja) 2005-11-23 2006-11-21 医薬組成物

Country Status (17)

Country Link
US (1) US20090028943A1 (cg-RX-API-DMAC7.html)
EP (2) EP1954247A1 (cg-RX-API-DMAC7.html)
JP (1) JP2009516726A (cg-RX-API-DMAC7.html)
KR (1) KR20080070056A (cg-RX-API-DMAC7.html)
CN (2) CN101312715B (cg-RX-API-DMAC7.html)
AR (1) AR057928A1 (cg-RX-API-DMAC7.html)
AU (1) AU2006318946A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0618906A2 (cg-RX-API-DMAC7.html)
CA (1) CA2628917A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP088555A (cg-RX-API-DMAC7.html)
GB (1) GB0523810D0 (cg-RX-API-DMAC7.html)
NO (1) NO20082097L (cg-RX-API-DMAC7.html)
RU (1) RU2008125197A (cg-RX-API-DMAC7.html)
TW (1) TW200735875A (cg-RX-API-DMAC7.html)
UY (1) UY29952A1 (cg-RX-API-DMAC7.html)
WO (1) WO2007060402A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200804103B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE05345B1 (et) 1999-02-10 2010-10-15 Astrazeneca Ab Kinasoliini derivaadid angiogeneesi inhibiitoritena
GB0330002D0 (en) * 2003-12-24 2004-01-28 Astrazeneca Ab Quinazoline derivatives
EP2299982B1 (de) * 2008-06-20 2018-04-04 Merck Patent GmbH Direkt verpressbare und schnell zerfallende tablettenmatirx
WO2010005527A1 (en) 2008-06-30 2010-01-14 Angioblast Systems, Inc. Treatment of eye diseases and excessive neovascularization using a combined therapy
TW201129386A (en) * 2009-11-05 2011-09-01 Fmc Corp Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
WO2013059740A1 (en) 2011-10-21 2013-04-25 Foundation Medicine, Inc. Novel alk and ntrk1 fusion molecules and uses thereof
EP2914621B1 (en) 2012-11-05 2023-06-07 Foundation Medicine, Inc. Novel ntrk1 fusion molecules and uses thereof
EP4223770A3 (en) 2012-11-05 2023-10-18 Foundation Medicine, Inc. Novel fusion molecules and uses thereof
CA2898326C (en) 2013-01-18 2022-05-17 Foundation Medicine, Inc. Methods of treating cholangiocarcinoma
IL296484B2 (en) 2013-06-06 2025-03-01 Fibrogen Inc Pharmaceutical formulations of HIF hydroxylase inhibitor
EP3414330A4 (en) 2016-02-08 2019-07-03 Vitrisa Therapeutics, Inc. COMPOSITIONS WITH IMPROVED INTRAVITREAL HALF TIME AND USES THEREOF
WO2020243021A2 (en) 2019-05-24 2020-12-03 Foundation Medicine, Inc. Ntrk fusion molecules and uses thereof
PE20221838A1 (es) * 2020-04-24 2022-11-29 Astrazeneca Ab Formulaciones farmaceuticas
CN115400136B (zh) * 2022-07-22 2023-10-03 江苏亚邦爱普森药业有限公司 一种克拉霉素固体制剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE05345B1 (et) 1999-02-10 2010-10-15 Astrazeneca Ab Kinasoliini derivaadid angiogeneesi inhibiitoritena
EP1175899B1 (fr) * 2000-07-27 2007-08-29 Roquette FrÀ¨res Granules à base d'amidon et de lactose
SE0101329D0 (sv) * 2001-04-12 2001-04-12 Astrazeneca Ab Pharmaceutical formulation
CA2363528A1 (en) * 2001-11-19 2003-05-19 Merck Patent Gesellschaft Mit Beschraenkter Haftung Immediate release tablet containing naproxen sodium
EP2292615A1 (en) * 2002-02-01 2011-03-09 AstraZeneca AB Quinazoline compounds
CA2488499C (en) * 2002-06-10 2013-03-19 Elan Pharma International Ltd. Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives ("statins"),combinations thereof as well as manufacturing of these pharmaceutical compositions
US20050043233A1 (en) * 2003-04-29 2005-02-24 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
GB0330002D0 (en) * 2003-12-24 2004-01-28 Astrazeneca Ab Quinazoline derivatives

Similar Documents

Publication Publication Date Title
CN105579031B (zh) 含有氨氯地平和缬沙坦的稳定药物组合物
HRP20151383T1 (hr) Farmaceutski pripravci koji sadrže nilotinib ili njegovu sol
CN101327213B (zh) 厄贝沙坦氢氯噻嗪药用组合物及其制备方法
CN105658208B (zh) 含甘磷酸胆碱的薄膜包衣片剂及其制备方法
US20230341173A1 (en) Wet granulation for manufacture of thermal insulation material
RU2008125197A (ru) Фармацевтические композиции
JP2015537066A5 (ja) 乾燥タイプの接合化合物組成物濃縮物
JP2012001473A5 (cg-RX-API-DMAC7.html)
HRP20161602T1 (hr) Postupak priprave čvrstog farmaceutskog pripravka
TWI498130B (zh) 以可直接壓縮高功能性粒狀微晶為主之賦形劑,其製造方法及用途
CN102846573B (zh) 水飞蓟宾双层缓释片及其制备方法
KR20100083047A (ko) 생체이용률이 향상된 발사르탄을 포함하는 약제학적 조성물
IL200447A0 (en) Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
TW201127776A (en) Humidity-controlling building material and method for producing same
JP2004243748A (ja) 表層材と内層材を一体化した建材の製造方法
CN1226434C (zh) 金属基复合材料增强相预构件的制备方法
JP2005508971A5 (cg-RX-API-DMAC7.html)
CN106167377B (zh) 一种用于根治内墙返潮结露的装饰板及其制备方法
WO2004006945A1 (ja) 漢方エキス含有錠剤組成物およびその製造方法
CN106220055B (zh) 一种防止内墙返潮结露的防护板及其制备方法
JP2007001875A5 (cg-RX-API-DMAC7.html)
KR101544943B1 (ko) 모델링 팩용 정제 조성물 및 이를 이용한 모델링 팩의 제조방법
CN1935264B (zh) 一种用于缓控释片的含有hpmc的新型复合辅料
CN102440993A (zh) 一种氨氯地平贝那普利片剂及其制备方法
JP2007056608A (ja) 壁材原料、壁材および壁材原料の製造方法